Anthony E Reeve

Summary

Country: New Zealand

Publications

  1. ncbi Insulin-like growth factor-II imprinting in cancer
    Anthony E Reeve
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Lancet 359:2050-1. 2002
  2. ncbi Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway
    Ryuji Fukuzawa
    Department of Biochemistry, Cancer Genetics Laboratory, University of Otago, P O Box 56, Dunedin, New Zealand
    Pediatr Dev Pathol 7:125-37. 2004
  3. ncbi Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors
    Ryuji Fukuzawa
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, PO Box 56, Dunedin, New Zealand
    J Pediatr Hematol Oncol 29:589-94. 2007
  4. doi Global demethylation in loss of imprinting subtype of Wilms tumor
    Jackie L Ludgate
    Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
    Genes Chromosomes Cancer 52:174-84. 2013
  5. pmc Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies
    Ryuji Fukuzawa
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    J Clin Pathol 60:1013-6. 2007
  6. ncbi Epigenetic differences between Wilms' tumours in white and east-Asian children
    Ryuji Fukuzawa
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Lancet 363:446-51. 2004
  7. doi Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients
    Adam Girardin
    Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
    Int J Cancer 132:1842-50. 2013
  8. ncbi Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer
    Bostjan Humar
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Cancer Res 67:2480-9. 2007
  9. pmc T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer
    Roslyn A Kemp
    Cancer Genetics Laboratory, University of Otago, Dunedin, New Zealand
    J Exp Clin Cancer Res 30:78. 2011
  10. ncbi Chromosome 14q LOH in localized clear cell renal cell carcinoma
    Kenji Mitsumori
    Department of Biochemistry, University of Otago, Dunedin, New Zealand
    J Pathol 198:110-4. 2002

Collaborators

Detail Information

Publications17

  1. ncbi Insulin-like growth factor-II imprinting in cancer
    Anthony E Reeve
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Lancet 359:2050-1. 2002
  2. ncbi Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway
    Ryuji Fukuzawa
    Department of Biochemistry, Cancer Genetics Laboratory, University of Otago, P O Box 56, Dunedin, New Zealand
    Pediatr Dev Pathol 7:125-37. 2004
    ....
  3. ncbi Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors
    Ryuji Fukuzawa
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, PO Box 56, Dunedin, New Zealand
    J Pediatr Hematol Oncol 29:589-94. 2007
    ....
  4. doi Global demethylation in loss of imprinting subtype of Wilms tumor
    Jackie L Ludgate
    Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
    Genes Chromosomes Cancer 52:174-84. 2013
    ..This would suggest that the LOI subtype of Wilms tumor, which unlike other subtypes results from an epimutation, has a global deregulation of methylation mechanisms...
  5. pmc Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies
    Ryuji Fukuzawa
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    J Clin Pathol 60:1013-6. 2007
    ..ILNR-associated Wilms tumours have a co-clustering of WT1 and beta-catenin (CTNNB1) mutations and unique histological features characterised by a stromal-predominant histology...
  6. ncbi Epigenetic differences between Wilms' tumours in white and east-Asian children
    Ryuji Fukuzawa
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Lancet 363:446-51. 2004
    ..We investigated whether the difference in incidence of Wilms' tumour between children of east-Asian descent and white children is due to variations in proportion of tumours with loss of IGF2 imprinting (IGF2 LOI)...
  7. doi Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients
    Adam Girardin
    Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
    Int J Cancer 132:1842-50. 2013
    ..These findings may be used to improve diagnosis and prognosis of colorectal cancer patients...
  8. ncbi Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer
    Bostjan Humar
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Cancer Res 67:2480-9. 2007
    ....
  9. pmc T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer
    Roslyn A Kemp
    Cancer Genetics Laboratory, University of Otago, Dunedin, New Zealand
    J Exp Clin Cancer Res 30:78. 2011
    ..No previous studies have characterized the T cell response in the regional lymph nodes in CRC...
  10. ncbi Chromosome 14q LOH in localized clear cell renal cell carcinoma
    Kenji Mitsumori
    Department of Biochemistry, University of Otago, Dunedin, New Zealand
    J Pathol 198:110-4. 2002
    ....
  11. doi WTX mutations can occur both early and late in the pathogenesis of Wilms tumour
    Ryuji Fukuzawa
    Department of Women s and Children s Health, Dunedin School of Medicine, University of Otago, PO Box 913 Dunedin, New Zealand
    J Med Genet 47:791-4. 2010
    ..One explanation may be that a somatic mutation in WTX may need to occur late in tumour development to contribute to tumourigenesis...
  12. pmc Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition
    Bostjan Humar
    Cancer Genetics Laboratory, Department of Biochemistry University of Otago, Dunedin, Aotearoa New Zealand
    Biologics 2:329-37. 2008
    ..Further, the shared inhibition of the WNT pathway by APHS suggests one potential common mechanism behind the antineoplastic effects of COX-2 inhibition...
  13. ncbi Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression
    Natalie J Kerr
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Med Pediatr Oncol 39:52-4. 2002
  14. ncbi A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X
    Rosemary W Heathcott
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Hum Mutat 19:462. 2002
    ..This patient extends the range and variation of phenotypes that may arise from a specific germline mutation in WT1...
  15. ncbi Re: Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor
    Ian M Morison
    J Natl Cancer Inst 94:1809; author reply 1809-10. 2002
  16. ncbi Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer
    Yu Hsin Lin
    Authors Affiliations Cancer Genetics Laboratory and Departments of Biochemistry, Medical and Surgical Sciences, and Pathology, University of Otago
    Clin Cancer Res 13:498-507. 2007
    ..We investigated whether gene classifiers derived from two tumor series using different array platforms could be independently validated by application to the alternate series of patients...
  17. ncbi Correct usage of "loss of imprinting"
    Ryuji Fukuzawa
    Am J Med Genet A 138:412; author reply 413-4. 2005